Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Redhill Biopharma Ltd. (RDHL) Normalized Income after Taxes data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Normalized Income after Taxes |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$12.55M |
|
$0.13M |
|
$5.82M |
|
$18.38M |
|
$22.29M |
|
-- |
|
$0.50M |
|
$22.79M |
|
$-4.41M |
|
$-9.94M |
|
$-4.41M |
|
-- |
|
| Cash Flow Statement Financials | |
$-5.01M |
|
$-0.00M |
|
$3.26M |
|
$4.62M |
|
$2.87M |
|
$-1.75M |
|
$0.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|